Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Andrew J. Epstein, PhD
Advertisement
Articles by Andrew J. Epstein, PhD
Federal parity led to an increase in spending on substance use disorder treatment.
Advertisement
Latest Updated Articles
- The Effects of Federal Parity on Substance Use Disorder Treatment
January 23rd 2014
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
FDA Approves Novel Iberdomide Regimen in RRMM
5